18 min listen
The AML Sessions: IDH inhibitors
FromVJHemOnc Podcast
ratings:
Length:
26 minutes
Released:
Nov 3, 2020
Format:
Podcast episode
Description
IDH mutations are present in 20% of acute myeloid leukemia (AML) patients and the use of IDH-targeting agents has shown...
The post The AML Sessions: IDH inhibitors appeared first on VJHemOnc.
The post The AML Sessions: IDH inhibitors appeared first on VJHemOnc.
Released:
Nov 3, 2020
Format:
Podcast episode
Titles in the series (100)
MRD testing in multiple myeloma: new technology with promising clinical applications: Determining measurable residual disease (MRD) status is undoubtedly proving to be an effective method of prognostication and measurement of response... by VJHemOnc Podcast